71 related articles for article (PubMed ID: 7008236)
1. [Weight loss by treatment with Fugoa depot. Results of a double blind study].
Muth H; Issmeier G
Ther Ggw; 1980 Oct; 119(10):1173-83. PubMed ID: 7008236
[No Abstract] [Full Text] [Related]
2. A double-blind clinical evaluation of the anorectic activity of phenylpropanolamine versus placebo.
Greenway F
Clin Ther; 1989; 11(5):584-9. PubMed ID: 2680083
[TBL] [Abstract][Full Text] [Related]
3. [Ephedrine in the treatment of obesity. A double-blind cross-over trial of the effect of Elsinore tablets].
Lumholtz IB; Thorsteinsson B; Wamberg T; Lehnschau A; Hansen G; Spellerberg S; Lund B
Ugeskr Laeger; 1980 Jun; 142(23):1487-90. PubMed ID: 6996251
[No Abstract] [Full Text] [Related]
4. A double blind clinical evaluation of a phenylpropanolamine-caffeine-vitamine combination and a placebo in the treatment of exogenous obesity.
Griboff SI; Berman R
Curr Ther Res Clin Exp; 1975 Jun; 17(6):535-43. PubMed ID: 808376
[No Abstract] [Full Text] [Related]
5. Three controlled trials of weight loss with phenylpropanolamine.
Altschuler S; Conte A; Sebok M; Marlin RL; Winick C
Int J Obes; 1982; 6(6):549-56. PubMed ID: 6761288
[TBL] [Abstract][Full Text] [Related]
6. A nasal decongestant and a local anesthetic for weight control?
Med Lett Drugs Ther; 1979 Aug; 21(16):65-6. PubMed ID: 379565
[No Abstract] [Full Text] [Related]
7. [Effect of Elsinore tablets in the treatment of obesity. A controlled clinical trial].
Malchow-Møller A; Larsen S; Hey H; Stokholm KH; Juhl E; Quaade F
Ugeskr Laeger; 1980 Jun; 142(23):1496-9. PubMed ID: 6996253
[No Abstract] [Full Text] [Related]
8. [Elsinore tablets and ephedrine as slimming agents].
Jensen KB; Danø P; Draeby N; Hansen SH; Kanstrup J
Ugeskr Laeger; 1980 Jun; 142(23):1499-501. PubMed ID: 6996254
[No Abstract] [Full Text] [Related]
9. Phenylpropanolamine for weight reduction.
Med Lett Drugs Ther; 1984 Jun; 26(663):55-6. PubMed ID: 6374401
[No Abstract] [Full Text] [Related]
10. [Therapy of obesity. The initial and continued effectiveness of tenuate in intermittent therapy of moderately and severely obese patients. Double-blind study].
Albach E; Gianoli AC
Fortschr Med; 1977 Sep; 95(33):2040-4. PubMed ID: 334650
[No Abstract] [Full Text] [Related]
11. Double-blind, randomized, placebo-controlled clinical trials with non-prescription medications for the treatment of obesity.
Greenway F; Herber D; Raum W; Herber D; Morales S
Obes Res; 1999 Jul; 7(4):370-8. PubMed ID: 10440593
[TBL] [Abstract][Full Text] [Related]
12. Double blind trial in general practice comparing the efficacy of "Benylin Day and Night" and paracetamol in the treatment of the common cold.
Middleton RS
Br J Clin Pract; 1981 Sep; 35(9):297-300. PubMed ID: 7034759
[No Abstract] [Full Text] [Related]
13. Weight reduction with phenmetrazine: a double-blind study.
Hadler AJ
Curr Ther Res Clin Exp; 1967 Sep; 9(9):462-7. PubMed ID: 4963979
[No Abstract] [Full Text] [Related]
14. A double-blind clinical trial of fenfluramine in the treatment of obesity.
Sainani GS; Fulambarkar AM; Khurana BK
Br J Clin Pract; 1973 Apr; 27(4):136-8. PubMed ID: 4586636
[No Abstract] [Full Text] [Related]
15. A double-blind clinical evaluation of the safety and efficacy of phentermine hydrochloride (Fastin) in the treatment of exogenous obesity.
Langlois KJ; Forbes JA; Bell GW; Grant GF
Curr Ther Res Clin Exp; 1974 Apr; 16(4):289-96. PubMed ID: 4208343
[No Abstract] [Full Text] [Related]
16. Minimization--a method of obtaining comparable groups in clinical trials.
Weis OF; Luus HG; Müller FO
S Afr Med J; 1984 Aug; 66(5):180-2. PubMed ID: 6463794
[TBL] [Abstract][Full Text] [Related]
17. Effects of sibutramine on body weight and serum lipids: a double-blind, randomized, placebo-controlled study in 322 overweight and obese patients with dyslipidemia.
Dujovne CA; Zavoral JH; Rowe E; Mendel CM;
Am Heart J; 2001 Sep; 142(3):489-97. PubMed ID: 11526363
[TBL] [Abstract][Full Text] [Related]
18. Effect of a proprietary Magnolia and Phellodendron extract on weight management: a pilot, double-blind, placebo-controlled clinical trial.
Garrison R; Chambliss WG
Altern Ther Health Med; 2006; 12(1):50-4. PubMed ID: 16454147
[TBL] [Abstract][Full Text] [Related]
19. Combination of diet, exercise and intermittent treatment of cimetidine on body weight and maintenance of weight loss. A 42 months follow-up study.
Birketvedt GS; Thom E; Bernersen B; Florholmen J
Med Sci Monit; 2000; 6(4):699-703. PubMed ID: 11208394
[TBL] [Abstract][Full Text] [Related]
20. Management of the overweight patients with cardiovascular disease: double-blind evaluation of an anorectic drug, diethylpropion hydrochloride.
Evanselista I
Curr Ther Res Clin Exp; 1968 May; 10(5):217-22. PubMed ID: 4967733
[No Abstract] [Full Text] [Related]
[Next] [New Search]
